Video

Assay for Ductal Carcinoma In Situ

Publish date: January 6, 2012

 

SAN ANTONIO – The Oncology Report's editor-in-chief, Dr. Howard A. Burris III, and its associate editor Dr. William J. Gradishar discuss an ONCOTYPE DX assay for ductal carcinoma in situ at the 2011 San Antonio Breast Cancer Symposium.

Recommended Reading

Less Trastuzumab Cardiotoxicity in Beta-Blocker Users
Breast Cancer ICYMI
Pegfilgrastim Costly, Unnecessary in Some Breast Cancer Patients
Breast Cancer ICYMI
Adjuvant Ibandronate: No Gain in Early Breast Cancer
Breast Cancer ICYMI
Program Curbs Shoulder Morbidity Post Breast Cancer
Breast Cancer ICYMI
Cancer Death Rates Continue to Drop
Breast Cancer ICYMI
Do Bisphosphonates Reduce Cancer Risks?
Breast Cancer ICYMI
Anastrozole and Fulvestrant in Hormone Receptor-Positive Breast Cancer
Breast Cancer ICYMI
Bisphosphonates as Antitumor Agents in Breast Cancer
Breast Cancer ICYMI
Community Oncology Podcast - Radiation in breast cancer
Breast Cancer ICYMI
Retrospective Study of Patients with Metastatic Triple-Negative Breast Cancer: Survival, Health Care Utilization, and Cost
Breast Cancer ICYMI